Can a new drug tackle Hard-to-Treat gynecologic cancers?
NCT ID NCT07755436
First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time
Summary
This early-stage trial is testing an investigational drug called ARR-002 in adults with advanced or metastatic ovarian or endometrial cancer, including cases that have stopped responding to platinum-based chemotherapy. The main goals are to assess the drug's safety, tolerability, and how the body processes it, while also looking for early signs that it can shrink tumors. Participants must have measurable disease and provide a tumor sample for testing.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ARR-002, an investigational drug
- What this could lead to
- If successful, ARR-002 could offer a new treatment option for people with advanced ovarian or endometrial cancer that has stopped responding to standard therapy.
- What could go wrong
- This is an early-phase trial focused on safety and dosing, so it is not yet known if ARR-002 will effectively shrink tumors or improve outcomes. Side effects and limited benefit are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NEXT Oncology
RECRUITINGIrving, Texas, 75039, United States
-
NEXT Oncology
RECRUITINGFairfax, Virginia, 22031, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- What raises endometrial cancer risk in black women? a study digs in
- Can a new PET tracer light up hidden cancers?
- A Two-for-One surgery: could tube removal during Weight-Loss surgery slash ovarian cancer risk?
- Can AI spot ovarian cancer on CT scans before It's too late?
- Can Lab-Grown tumors unlock the secrets of ovarian cancer resistance?